Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wein

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
ACS Central Science|April 27, 2026
Propellane Alkaloid Biosynthesis and Total Synthesis via Interrupted Reaction PathwaysJohn M Billingsley, Jiaming Ding, Allison T Hands, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 11, 2016
Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassificationS Merkel, K Weber, R S Croner, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
British Journal of Cancer|June 9, 2005
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancerM Moehler, A Eimermacher, J Siebler, et al.
British Journal of Cancer|December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation studyJ T Hartmann, K Oechsle, D Quietzsch, et al.
Urology|September 11, 2001
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screeningA V D'Amico, R Whittington, S B Malkowicz, et al.
Anticancer Research|February 24, 2001
Mismatch repair deficiency in sporadic synchronous colorectal cancerW M Brueckl, T Limmert, T Brabletz, et al.
British Journal of Cancer|November 12, 2009
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsA D Wagner, P Buechner-Steudel, M Moehler, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
ACS Central Science|April 27, 2026
Propellane Alkaloid Biosynthesis and Total Synthesis via Interrupted Reaction PathwaysJohn M Billingsley, Jiaming Ding, Allison T Hands, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 11, 2016
Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassificationS Merkel, K Weber, R S Croner, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
British Journal of Cancer|June 9, 2005
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancerM Moehler, A Eimermacher, J Siebler, et al.
British Journal of Cancer|December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation studyJ T Hartmann, K Oechsle, D Quietzsch, et al.
Urology|September 11, 2001
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screeningA V D'Amico, R Whittington, S B Malkowicz, et al.
Anticancer Research|February 24, 2001
Mismatch repair deficiency in sporadic synchronous colorectal cancerW M Brueckl, T Limmert, T Brabletz, et al.
British Journal of Cancer|November 12, 2009
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsA D Wagner, P Buechner-Steudel, M Moehler, et al.
Pageof 11